Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2643: 3; text: CR S2669: 2)
This resolution expresses the Senate's support for National Fentanyl Awareness Day on April 29, 2025, and highlights concerns about fake or counterfeit fentanyl pills. It applauds law enforcement, encourages using existing authorities to prevent counterfeit pills, and urges increased public awareness of risks to families and young people. In practice it is a formal statement and a one-day designation by the Senate and does not create new laws, funding, or enforceable requirements.
This is a Senate-only simple resolution agreed to by the Senate; it is not sent to the President and does not have the force of law. It is a non-binding expression of the Senate's views and a formal day designation.
This Senate resolution designates April 29, 2025, as National Fentanyl Awareness Day and expresses support for its mission to increase public awareness about fake or counterfeit fentanyl pills.
It cites DEA seizure and overdose statistics, applauds federal, state, and local law enforcement efforts, and encourages use of existing authorities to prevent the spread of counterfeit pills.
The resolution is symbolic and does not appropriate funding or create new law.
Content is symbolic, bipartisan, low-cost, and historically such awareness-day resolutions are very likely to be agreed to.
Relative to its intended legislative type, this bill is a well-formed commemorative resolution: it clearly defines the issue in its preamble, designates a specific day, and uses appropriate, limited operative language (support, applause, encouragement) consistent with symbolic action. It contains a minor administrative element by urging use of existing authorities, but it does not create new legal obligations, appropriations, or reporting requirements.
Progressive wants treatment and harm-reduction emphasis; conservatives emphasize enforcement.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressive wants treatment and harm-reduction emphasis; conservatives emphasize enforcement.
Generally supportive of awareness and protecting young people, but wary of the emphasis on law enforcement rather than public-health responses.
Would want the resolution paired with treatment, harm reduction, education, and measures to avoid stigmatizing people with substance use disorders.
Views the symbolic designation as useful if it leads to evidence-based prevention and resources.
Likely supportive as a nonbinding, bipartisan resolution that raises awareness of a documented public-health problem.
Sees value in public education and applauding enforcement, but notes this is symbolic and effectiveness depends on implementation and coordination with prevention and treatment programs.
Strongly supportive of drawing attention to illicit fentanyl and counterfeit pills and of applauding law enforcement actions.
Views the resolution as a sober recognition of a national security and public-safety problem and a useful, low-cost federal signal to reinforce interdiction and prosecution priorities.
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Still ahead
Content is symbolic, bipartisan, low-cost, and historically such awareness-day resolutions are very likely to be agreed to.
The bill has not accumulated any surfaced votes yet.
Progressive wants treatment and harm-reduction emphasis; conservatives emphasize enforcement.
Content is symbolic, bipartisan, low-cost, and historically such awareness-day resolutions are very likely to be agreed to.
Relative to its intended legislative type, this bill is a well-formed commemorative resolution: it clearly defines the issue in its preamble, designates a specific day, and uses appropriate, limited operative language (…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.